LFCR
LFCR
NASDAQ · Life Sciences Tools & Services

Lifecore Biomedical Inc

$4.38
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
75.30M
Net Income
-17,907,900
Gross Margin
31.4%
Profit Margin
-23.8%
Rev Growth
-9.9%
D/E Ratio
4.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.4% 31.4% 44.5% 44.5%
Operating Margin -1.0% -0.9% 6.5% 6.6%
Profit Margin -23.8% -22.6% 5.3% 5.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 75.30M 83.59M 344.67M 265.26M
Gross Profit 23.62M 26.22M 153.43M 118.09M
Operating Income -730,428 -729,698 22.32M 17.47M
Net Income -17,907,900 -17,890,009 18.11M 14.22M
Gross Margin 31.4% 31.4% 44.5% 44.5%
Operating Margin -1.0% -0.9% 6.5% 6.6%
Profit Margin -23.8% -22.6% 5.3% 5.4%
Rev Growth -9.9% -9.9% +6.7% +0.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 68.26M 68.26M 31.30M 33.69M
Total Equity 16.32M 16.32M 172.81M 150.13M
D/E Ratio 4.18 4.18 0.18 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 3.48M 3.67M 26.32M 22.29M
Free Cash Flow 8.29M 10.33M